Ashok K Varma

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Acute Myeloid Leukemia

Molecular Docking

Top Venues

The FEBS journal

Journal of cellular biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Suchita Dubey, Neha Mishra, Rohan Shelke, Ashok K Varma
Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. The FEBS journal (2023)
Vaishnvee Chikhale, Nabajyoti Goswami, Mudassar Ali Khan, Probodh Borah, Ashok K Varma
Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1. ACS omega 8 (18) (2023)
Aaliya Anwaar, Ashok K Varma, Reshita Baruah
In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins. ACS omega 8 (11) (2023)
Vaishnvee Chikhale, Nabajyoti Goswami, Mudassar Ali Khan, Probodh Borah, Ashok K Varma
Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1. ACS omega 8 (18) (2023)
Venessa Colaco, Nabajyoti Goswami, Vijay Kumar Goel, Sunil Kumar Srivastava, Pachuau Lalrohlua, Nachimuthu Senthil Kumar, Probodh Borah, Reshita Baruah, Ashok K Varma
In silico and structure-based evaluation of deleterious mutations identified in human Chk1, Chk2, and Wee1 protein kinase. Journal of cellular biochemistry (2023)
Vaishnvee Chikhale, Nabajyoti Goswami, Mudassar Ali Khan, Probodh Borah, Ashok K Varma
Evaluation of Pathogenicity and Structural Alterations for the Mutations Identified in the Conserved Region of the C-Terminal Kinase Domain of Human-Ribosomal S6 Kinase 1. ACS omega 8 (18) (2023)
Suchita Dubey, Neha Mishra, Rohan Shelke, Ashok K Varma
Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. The FEBS journal (2023)
Neha Mishra, Suchita Dubey, Anchala Kumari, Mudassar Ali Khan, Ekaterina S Kuligina, Elena V Preobrazhenskaya, Alexandr A Romanko, Lumbini R Yadav, Rajiv Sarin, Evgeny N Imyanitov, Ashok K Varma
Structural implications of amyloidogenic rare variants Ser282Leu and Gln356Arg identified in h-BRCA1. Proteins (2023)
Suchita Dubey, Neha Mishra, Rohan Shelke, Ashok K Varma
Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. The FEBS journal 291 (7) (2023)
Suchita Dubey, Neha Mishra, Rohan Shelke, Ashok K Varma
Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. The FEBS journal 291 (7) (2023)
Aaliya Anwaar, Ashok K Varma, Reshita Baruah
In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins. ACS omega 8 (11) (2023)
Siddhartha A Barua, Nabajyoti Goswami, Neha Mishra, Ulka U Sawant, Ashok K Varma
In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern. ACS omega 7 (49) (2022)
Siddhartha A Barua, Nabajyoti Goswami, Neha Mishra, Ulka U Sawant, Ashok K Varma
In Silico and Structure-Based Assessment of Similar Variants Discovered in Tandem Repeats of BRCT Domains of BRCA1 and BARD1 To Characterize the Folding Pattern. ACS omega 7 (49) (2022)
Lipi Das, Shashank Shekhar, Pratik Chandrani, Ashok K Varma
In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions. Journal of biomolecular structure & dynamics (2021)
Rajan Kumar Choudhary, M Quadir Siddiqui, Nikhil Gadewal, Nachimuthu Senthil Kumar, Ekaterina S Kuligina, Ashok K Varma
Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain. RSC advances 8 (59) (2018)